Mounjaro can be powerful. It's even more powerful with a physician actually watching how your body responds.
In short: if you have type 2 diabetes and want to lose weight, Mounjaro (tirzepatide) may help with both. It's a once-weekly injection FDA-approved for type 2 diabetes, and it's the same medicine as Zepbound, which is approved for weight management. If you don't have diabetes, Zepbound is usually the version a physician will discuss.
Bryan went from a playing weight in football to putting on weight. Working with Dr. Billing, he lost almost 200 pounds and regained his life.
Skye spent a lifetime struggling with her weight. After learning about her options and talking with Dr. Billing, she found a solution that was right for her.
Sean reached a point where he wanted a serious effort and a long-term solution for himself and his family. He lost weight and found a sustainable path forward.
Explore flexible payment options with Cherry.
Mounjaro is tirzepatide, a once-weekly injection FDA-approved to improve blood sugar in adults with type 2 diabetes. It isn’t approved for weight loss on its own. The same medicine is approved for weight management under a different name: Zepbound.
So the real question isn’t “Mounjaro or not.” It’s which version of tirzepatide, if any, matches your health and your coverage.
If you don’t have type 2 diabetes, your physician will usually talk with you about Zepbound, which is the same medicine approved for weight management. Using Mounjaro only for weight loss is off-label.
Mounjaro acts on two hormone pathways, GLP-1 and GIP. Together they help your body release insulin when blood sugar rises, reduce the amount of sugar your liver releases, slow digestion, and reduce appetite. For many people with diabetes, blood sugar and weight improve together.
Mounjaro can have gastrointestinal side effects. Managing those side effects is part of the care.
The most common are nausea, diarrhea, vomiting, constipation, and stomach discomfort. They tend to show up as the dose goes up and often ease with time. Going at the right pace is a big part of what your physician manages, and the goal is always the same: find the right dose for you.
Mounjaro carries a boxed warning about thyroid C-cell tumors seen in animal studies, and it should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Other serious risks include pancreatitis, gallbladder problems, kidney problems, and low blood sugar when combined with certain diabetes medicines. It is not for use during pregnancy. Your physician reviews the full prescribing information and your health history before anything is prescribed.
Like Zepbound, Mounjaro can make birth control pills less effective for a period after starting and after each dose increase.
Without insurance, the list price for Mounjaro is roughly $1,000 a month or more. Coverage depends on your plan and usually follows the FDA-approved use, so most plans cover Mounjaro for type 2 diabetes and not for weight loss alone.
Our team verifies your benefits before you start and walks you through cash-pay and financing options. Prices change often; our cost and insurance guide has current numbers.
Diabetes and weight are treated as one problem here, because for most people they are. Your physician decides with you between Mounjaro and Zepbound based on whether you have diabetes and what your plan covers. As your blood sugar comes down, your other diabetes medicines are adjusted so that lower doesn’t become too low. And your metabolism is measured, not guessed, with biometric testing that shows what’s changing beyond the scale.
If medication isn’t enough, gastric bypass and SADI-S are known for strong results with type 2 diabetes, and the same team performs them.
Bottom line: Mounjaro and Zepbound are the same medicine with different approvals. Which one you should take comes down to whether you have type 2 diabetes and what your plan covers, and that’s a five-minute conversation with your physician, not a guess.
Mounjaro is FDA-approved for type 2 diabetes, so using it only for weight loss is off-label. The same medicine is approved for weight management as Zepbound, which is usually the option a physician will discuss.
Both contain tirzepatide. Mounjaro is approved for type 2 diabetes, and Zepbound is approved for chronic weight management and obstructive sleep apnea in adults with obesity.
Insurance usually covers Mounjaro for type 2 diabetes. Coverage for weight loss alone is uncommon. Our team verifies your benefits before you start.
It can. If you take insulin or medicines that lower blood sugar, your physician may adjust those doses to help prevent low blood sugar.
Mounjaro was studied in people with type 2 diabetes, where weight loss was a secondary result. The same medicine, studied for weight loss as Zepbound, produced about 21% average weight loss at the highest dose over 72 weeks.
Rarely. Insurance usually covers Mounjaro for type 2 diabetes. For weight loss coverage, plans typically look at Zepbound or Wegovy, which are approved for weight management.
